Generic name: lurbinectedin (for injection)
Drug class:Alkylating agents
What is Zepzelca?
- Zepzelca is used to treat adults with a kind of lung cancer called small cell lung cancer (SCLC).
Zepzelca may be used when your lung cancer:- has spread to other parts of the body (metastatic), and
- you have received treatment with chemotherapy that contains platinum, and it did not work or is no longer working.
It is not known if this medicine is safe and effective in children.
Before receiving Zepzelca
Before receiving Zepzelca, tell your healthcare provider about all of your medical conditions, including if you:
- have liver or kidney problems.
- are pregnant or plan to become pregnant. Zepzelca can harm your unborn baby.
Females who are able to become pregnant:- Your healthcare provider should do a pregnancy test before you start treatment.
- You should use effective birth control (contraception) during treatment with and for 6 months after your final dose.
- Tell your healthcare provider right away if you become pregnant or think that you are pregnant during treatment.
Males with female partners who are able to become pregnant should use effective birth control during treatment with and for 4 months after your final dose.
- are breastfeeding or plan to breastfeed. It is not known if Zepzelca passes into your breastmilk.
Do not breastfeed during treatment, and for 2 weeks after your final dose. Talk to your healthcare provider about the best way to feed your baby during treatment.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Certain other medicines may affect how Zepzelca works. Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.
MEDICAL DEPARTMENTS
Cardiology
Pediatrics
Diabetes Care
Pre-natal Care
Ultrasound Echocardiogram
MEDICAL DEPARTMENTS
Cardiology
Pediatrics
Diabetes Care
Pre-natal Care
Ultrasound Echocardiogram